{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Ffaq-nsclc-immunotherapy-XK637H7W","width":444,"version":"1.0","type":"rich","title":"Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/46a5e39c-78b4-4df4-bbd8-d278a752eb82/lung-io-ss-iaslc-wclc-podcasticon-faq.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/3743809e-5c3c-42be-90be-474ae1466756\" height=\"200\" width=\"100%\" title=\"Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast episode, listen to lung cancer experts Julie Brahmer, MD, MSc, and Jarushka Naidoo, MB BCH BAO, MHS, answer audience questions from a live CCO webinar on evolving immunotherapy strategies for patients with early-stage and advanced NSCLC."}